|
1 |
Creative Commons |
The Pandemic People: Sir Pascal Soriot |
Sir Andrew Pollard talks to Sir Pascal Soriot, the CEO of AstraZeneca about their pandemic partnership to develop the AstraZeneca/Oxford vaccine. Over three billion vaccines have been delivered, saving six and a half million lives. |
Andrew Pollard, Pascal Soriot |
27 Nov 2023 |
|
2 |
|
A War on People: The Drug War and the Hermeneutic Politics of Those who Resist it |
This Anthropology Departmental Seminar was given by Jarrett Zigon (University of Virginia) on 2 December 2016. |
Jarrett Zigon |
31 Jul 2017 |
|
3 |
|
Drug and Target Discovery in Parkinson's Disease |
Prof. Richard Wade-Martins discusses how you pick promising new drugs targets for Parkinson's |
Richard Wade-Martins |
05 Jul 2016 |
|
4 |
Creative Commons |
Research, Policy, and Societal Perspectives on New Psychoactive Substances |
Part four of the 'Interventional Perspectives on Substance Use and Misuse' seminar series which took place in Hilary Term 2014. |
Harry Sumnall |
19 May 2015 |
|
5 |
Creative Commons |
Adolescent Substance Use: What Do We Think We Know, Should We Intervene and if so, When? |
Part two of the 'Interventional Perspectives on Substance Use and Misuse' seminar series which took place in Hilary Term 2014. |
Alex Sutherland |
19 May 2015 |
|
6 |
Creative Commons |
Drug Control, Human Rights and Bridging 'Parallel Universes' |
Part one of the 'Interventional Perspectives on Substance Use and Misuse' seminar series which took place in Hilary Term 2014. |
Rick Lines |
19 May 2015 |
|
7 |
Creative Commons |
Why do we need to reconstruct drug discovery? |
Dr Javier Lezaun and Professor Chas Bountra give a talk about drug discovery. |
Chas Bountra, Javier Lezaun |
17 Feb 2015 |
|
8 |
|
Part 4: A New Age of Drug Discovery |
You just have to step into your local chemist to see how far medicine has come over the past 100 years. Life changing drugs, which were once unthinkable – like antibiotics, insulin and the contraceptive pill – are now commonplace. |
Jonathan Webb |
05 Nov 2014 |
|
9 |
|
Why is Oxford Determined to Change the Way We Discover New Medicines? |
Chas Bountra, a popular speaker at the recent Meeting Minds: Alumni Weekend in Asia, will explain how Oxford is creating a new ecosystem for drug discovery. |
Chas Bountra |
07 Oct 2014 |
|
10 |
|
Deadly Devices and Dangerous Drugs, the Secrets Behind Medical Research |
A talk hosted by Kellogg College and the Centre for Evidence-Based Medicine at the University Museum of Natural History, as part of the University's Alumni Weekend. |
Carl Heneghan, Jeff Aronson, Deb Cohen, Ben Goldacre |
03 Oct 2014 |
|
11 |
|
Big Data and Drug Discovery (The Osler Discussion) |
'Big data' in medicine is an emerging field with the potential to revolutionise healthcare research.This session will look at how Oxford is addressing some of these research opportunities and challenges. |
Martin Landray |
04 Oct 2013 |
|
12 |
|
3D Printing and The Structure of Proteins |
Using 3D printed molecules, Rok Sekirnik, a DPhil student in the emerging field of chemical biology, shows how protein structures can be determined in some of the Department's most distinctive looking labs. |
Rok Sekirnik |
19 Jul 2013 |
|
13 |
Creative Commons |
OxPeace 2013: Illicitily Governed Spaces: drugs, conflict and peace in Columbia Session 1A: Counter-Terrorism and Peacebuilding |
Annette Idler, gives a talk for the OxPeace 2013 conference: The Future of Peace Building. |
Annette Idler |
21 May 2013 |
|
14 |
|
How can we get the media to tell the truth about drugs? |
Professor David Nutt (Imperial College London) delivers the 2011 Monica Fooks Memorial Lecture. |
David Nutt |
07 Dec 2011 |
|
15 |
Creative Commons |
Bio-Ethics Bites |
Demand for health care is infinite, but money is finite. So how should we distribute resources? Whom should we help, and why? |
Jonathan Wolf |
03 Oct 2011 |
|
16 |
|
Oxford at Said Seminar: Drug Discovery |
In this seminar two academics explore experimental medicine in early-phase clinical trials and reforming intellectual property. |
Vincenzo Libri, Chas Bountra |
04 Jul 2011 |
|
17 |
|
Medical Innovation 2010: Parallel Session 8 |
Financing Innovation: How can we utilise novel mechanisms to fund innovation? |
Rob James, Shelagh Wilson, Javier Guzman, Adrian Towse |
02 Aug 2010 |
|
18 |
|
Medical Innovation 2010: Parallel Session 7 |
Evaluating Innovation: How do we evaluate innovation appropriately? |
Stephen Richards, Kalipso Chalkidou, Robyn Norton, Paul Glasziou |
02 Aug 2010 |
|
19 |
|
Medical Innovation 2010: Parallel Session 6 |
Clinical Entrepreneurship. |
Oliver Bernath, Jake Arnold-Forster, Richard Darch, Mike Stein |
02 Aug 2010 |
|
20 |
|
Medical Innovation 2010: Parallel Session 5 |
Entrepreneurship in the Community. |
Pamela Hartigan, Joop Tanis, Andrea Coleman, Deborah Szebeko |
02 Aug 2010 |
|
21 |
|
Medical Innovation 2010: Parallel Session 4 |
Change and Innovation: What are the obstacles to change in complex health organisations in the UK? |
Sue Dopson, Keith Ruddle, Andrew Pettigrew, Allan Cole |
02 Aug 2010 |
|
22 |
|
Medical Innovation 2010: Parallel Session 2 |
Healthcare Service Innovations: How do we provide high quality healthcare with decreased resources globally? |
Steve Fairman, Keith Willet, Thulsi Ravilla, Peter McCulloch |
02 Aug 2010 |
|
23 |
|
Medical Innovation 2010: Parallel Session 1 |
Innovation to Practice: What are the challanges to bringing innovative drugs and devices into healthcare delivery and practice globally? |
Lionel Tarassenko, Constantin Coussios, Peter Dobson, Christopher Elias |
02 Aug 2010 |
|
24 |
|
Medical Innovation 2010: Opening Remarks and Keynote Address |
Opening remarks for the Medical Innovation 2010 Conference and a Keynote Address given by Prof Baron Peter Piot, The Institute for Global Health, Imperial College London, 'Harnessing Innovation to Meet the Challenges of a Changing Global Health Landscape' |
Sue Dopson, Andrew Hamilton, Peter Piot |
02 Aug 2010 |
|
25 |
|
Why it doesn't matter whether we're at war with al-Qaeda |
Anthony Dworkin (European Council on Foreign Relations) gives a talk for the Centre for Ethics, Law and Armed Conflict seminar series. |
Anthony Dworkin |
14 Jun 2010 |
|
26 |
|
The Mafia and the Mullah: Counternarcotics, Counterinsurgency and Realpolitik in Afghanistan |
Captain William Park (U.S. Navy Hudson Fellow, CCW Visiting Fellow and ELAC Research Associate) gives a talk for the Centre for Ethics, Law and Armed Conflict seminar series. |
William Park |
14 Jun 2010 |
|
27 |
|
Is there a healthy future for Big Pharma? |
Dr Patterson will review the background to the pharmaceutical crisis and the different ways that companies are approaching the issues. The lecture will review both the research and development and business issues facing the industry and its investors. |
John Patterson, Sophia Tickell |
04 Feb 2010 |
|
28 |
|
Is there a healthy future for Big Pharma? |
Dr Patterson will review the background to the pharmaceutical crisis and the different ways that companies are approaching the issues. The lecture will review both the research and development and business issues facing the industry and its investors. |
John Patterson, Sophia Tickell |
04 Feb 2010 |
|
29 |
|
A Pharma perspective on healthcare needs and innovation in drug discovery |
The third Green Templeton Lecture 2009 explores how, by harnessing innovation to meet unmet medical needs, pharma companies can deliver significant value to patients, payers and shareholders. |
Patrick Vallance, Philip Bloomer |
09 Jun 2009 |
|
30 |
|
A Pharma perspective on healthcare needs and innovation in drug discovery |
The third Green Templeton Lecture 2009 explores how, by harnessing innovation to meet unmet medical needs, pharma companies can deliver significant value to patients, payers and shareholders. |
Patrick Vallance, Philip Bloomer |
09 Jun 2009 |
|
31 |
|
Pharmaceutical Companies, Government and Society |
This lecture will explore, from a historical perspective, the relationship between an emerging pharmaceutical industry, the establishment of drug regulatory authorities, and - most recently - the development of health technology assessment. |
Sir Michael Rawlins |
04 Jun 2009 |
|
32 |
|
Pharmaceutical Companies, Government and Society |
This lecture will explore, from a historical perspective, the relationship between an emerging pharmaceutical industry, the establishment of drug regulatory authorities, and - most recently - the development of health technology assessment. |
Sir Michael Rawlins |
04 Jun 2009 |
|
33 |
|
Pharmaceutical Industry: Origin and Evolution |
Tilli Tansey, Professor of History of Modern Medical Sciences, University College London traces the evolution of the modern pharmaceutical industry from the mid nineteenth century to the final decades of the twentieth century. |
Tilli Tansey |
19 May 2009 |
|
34 |
|
Pharmaceutical Industry: Origin and Evolution |
Tilli Tansey, Professor of History of Modern Medical Sciences, University College London traces the evolution of the modern pharmaceutical industry from the mid nineteenth century to the final decades of the twentieth century. |
Tilli Tansey |
19 May 2009 |
|
35 |
|
Computer Aided Drug Design |
Prof. Graham Richards lectures at the Sutton Trust Chemistry Summer School, a week long workshop featuring chemistry lectures and lab work. |
Graham Richards |
24 Apr 2008 |
